News
LLY, NFLX, and GE lead today's top stock picks, with strong growth drivers but face headwinds from pricing, rivals, and costs ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
8h
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightDrugs like semaglutide, also known by the brand names Ozempic and Wegovy, have transformed how we treat obesity, but soaring demand has led to frequent supply shortages. In the US ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results